Physician profile
Patrick Dyer
NPI 1952895930
$8,081.27
in general payments reported to CMS, 2019-2025
49 companies · $2,893 in 2025
The $2,893 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $1,123 · 2023: $1,508 · 2024: $2,392 · 2025: $2,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,623 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,622.57 |
| Education | $170.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,020.44 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $964.01 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $824.59 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $552.23 | 2023-2025 | |
| Amgen INC. | $391.36 | 2021-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.40 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Astellas Pharma US INC | $326.52 | 2021-2025 | Veozah |
| Axsome Therapeutics, INC. | $313.83 | 2023-2025 | Auvelity |
| Exact Sciences Corporation | $267.51 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $256.94 | 2022-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $255.21 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $244.74 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Lundbeck LLC | $202.06 | 2022-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $200.68 | 2022-2025 | Zoryve, Livalo |
| Otsuka America Pharmaceutical, INC. | $187.92 | 2022-2025 | Rexulti |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $165.11 | 2024-2025 | |
| Antares Pharma, INC. | $137.92 | 2024-2025 | Xyosted |
| Corium, LLC | $136.83 | 2022-2025 | Azstarys |
| Phathom Pharmaceuticals, INC. | $132.86 | 2024-2025 | Voquezna |
| Abbott Laboratories | $122.23 | 2024-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $93.31 | 2022-2025 | |
| Noven Therapeutics, LLC | $81.18 | 2023-2025 | Xelstrym |
| Janssen Pharmaceuticals, INC | $72.68 | 2022 | |
| Tris Pharma INC | $53.97 | 2023-2024 | Dyanavel Xr |
| Bausch Health US, LLC | $51.52 | 2021-2022 | |
| Halozyme INC | $50.75 | 2023 | |
| Merck Sharp & Dohme LLC | $48.04 | 2021-2025 | Capvaxive, Gardasil 9 |
| Sumitomo Pharma America, INC. | $47.98 | 2024-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company Ltd. | $46.35 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $45.33 | 2024 | Exparel, Zilretta, Iovera |
| Verona Pharma, INC. | $38.08 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $33.88 | 2024-2025 | Camzyos |
| Alexion Pharmaceuticals, INC. | $33.84 | 2025 | Koselugo |
| Seqirus USA INC | $32.23 | 2022-2025 | Flucelvax, Fluad |
| Sunovion Pharmaceuticals INC. | $31.13 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $29.11 | 2022-2023 | Dupixent |
| Idorsia Pharmaceuticals US INC | $28.39 | 2023-2024 | Quviviq |
| Ucb, INC. | $27.00 | 2023 | |
| Impel Pharmaceuticals INC. | $20.48 | 2023 | Trudhesa |
| Actelion Pharmaceuticals US, INC. | $18.83 | 2024 | Uptravi, Opsumit |
| Corcept Therapeutics | $17.85 | 2024 | Korlym |
| Dexcom, INC. | $17.14 | 2024 | Dexcom G6 Transmitter |
| Vertex Pharmaceuticals Incorporated | $15.44 | 2025 | |
| Esperion Therapeutics, INC. | $15.43 | 2024 | Nexletol |
| Phadia US INC. | $14.93 | 2023 | Immunocap |
| Bioventus LLC | $14.59 | 2023 | Durolane |
| Almatica Pharma LLC | $14.34 | 2022 | |
| Echosens North America, INC. | $11.45 | 2025 | Fibroscan |
| Endogastric Solutions, INC | $7.63 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.